Four things to know:
1. Emgality is a CGRP inhibitor, a new class of drugs used to prevent or reduce the incidence of migraines.
2. Cluster headaches are recurring, intense headaches that can occur several times per day. Most cases are episodic, lasting in periods from seven days up to one year. Then the patient may experience a pain-free period. Some cases are chronic, with attacks occurring for more than a year without a pain-free period.
3. About 250,000 patients suffer from the condition in the U.S.
4. Emgality is an injectable treatment that is administered once a month. It costs $6,900 a year.
More articles on pharmacy:
Viewpoint: The $2.1M drug price record won’t last long
Purdue Pharma hit with 4 more opioid lawsuits: 4 things to know
EpiPen shortage will drag on: 4 things to know
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
